🔴 Jazz Pharmaceuticals is trading at 4.7% down as oil prices and Treasury yields rise

Jazz Pharmaceuticals is trading 4.7% lower at $220.37 amid broader market and healthcare-sector pressure, with no clear company-specific announcement explaining the decline.

• On October 8, 2026, a same-day report cited Middle East tensions, rising oil prices and Treasury yields; Brent gained 5% to $105.16 per barrel, while the 10-year yield remained near 5.35%.
• Healthcare stocks fell 1.49%.
• The CEO’s October 6 sale of 2,000 shares is not clearly linked to the move.